A new era in surgical innovation
We are excited to announce the expansion of the Symani Surgical System to the U.S. market. Surgeons can now access the technology for open, soft tissue reconstructive procedures and lymphatic repair.
About The Symani Surgical System
A first-of-its kind robotic technology that uniquely addresses the scale and complexities of microsurgery and supermicrosurgery
Pioneer your own robotics program
Pioneer your robotics program and elevate your practice. The Symani Surgical System has demonstrated its effectiveness in nearly 1,000 clinical cases in Europe.
It’s now available in the U.S. to help your hospital be at the forefront of surgical innovation.
Lead the way to better patient outcomes for breast reconstruction
Women with breast cancer deserve access to the very best post-mastectomy care options. With Symani, you’ll lead the way to better patient outcomes and quality of life, by offering an innovative, technology-enabled option for autologous breast reconstruction. Supported by advanced robotic capabilities and enhanced precision, you’ll help women at a pivotal time in their breast cancer journey and push the limits of what’s possible in breast reconstruction.
Clinical outcomes
As clinical experience and evidence supporting Symani’s application in microsurgical procedures continues to grow, we are excited to bring the benefits of robotic-assisted microsurgery to patients in the U.S.
Recent research has demonstrated a rapid technology learning curve, accelerated development of microsurgical skills, and the potential for higher success rates1 and reduced adverse events for patients.3
Explore Clinical Resources
Join us in shaping the future of microsurgery
Use the form to submit your contact details and we will get in touch with you.
CITATIONS
1. PRIMO PMCF clinical study. Data on file.
2. SAFE Microsurgery GLP preclinical study data on file.
3. Ballestin A, et al. Microsurgical robotic system enables the performance of microvascular anastomoses: a randomized in vivo preclinical trial. Sci Rep. 2023;13(1):14003. doi: 10.1038/s41598-023-41143-z. Data derived from animal models may not be predictive of human clinical experience. Score includes vessel reaction, inflammation, host reaction. Total average host reaction score compared to manual.
4. Data on file.
